Therapeutic Immunization against Mycobacterium tuberculosis Is an Effective Adjunct to Antibiotic Treatment
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic Immunization against Mycobacterium tuberculosis Is an Effective Adjunct to Antibiotic Treatment
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 207, Issue 8, Pages 1242-1252
Publisher
Oxford University Press (OUP)
Online
2012-08-14
DOI
10.1093/infdis/jis425
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A multistage tuberculosis vaccine that confers efficient protection before and after exposure
- (2011) Claus Aagaard et al. NATURE MEDICINE
- Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
- (2011) Rhea N. Coler et al. PLoS One
- Targeting TLRs Expands the Antibody Repertoire in Response to a Malaria Vaccine
- (2011) S. R. Wiley et al. Science Translational Medicine
- Polyfunctional T cells in human tuberculosis
- (2010) Katalin A. Wilkinson et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Anti-tuberculosis drug therapy in mice of different inbred strains
- (2010) Boris V. Nikonenko et al. INFECTION GENETICS AND EVOLUTION
- New vaccines for tuberculosis
- (2010) Stefan HE Kaufmann et al. LANCET
- Treatment of latent tuberculosis infection: An update
- (2010) Philip LOBUE et al. RESPIROLOGY
- Tuberculosis: What We Don't Know Can, and Does, Hurt Us
- (2010) D. G. Russell et al. SCIENCE
- A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant Mycobacterium tuberculosis
- (2010) S. Bertholet et al. Science Translational Medicine
- A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis
- (2010) Evaldo Nascimento et al. VACCINE
- Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations
- (2009) Ryan C. Anderson et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- A replication clock for Mycobacterium tuberculosis
- (2009) Wendy P Gill et al. NATURE MEDICINE
- Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys
- (2009) S. G. Reed et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Optimized subunit vaccine protects against experimental leishmaniasis
- (2009) Sylvie Bertholet et al. VACCINE
- Enhanced humoral and Type 1 cellular immune responses with Fluzone® adjuvanted with a synthetic TLR4 agonist formulated in an emulsion
- (2009) Susan L. Baldwin et al. VACCINE
- Intradermal immunization improves protective efficacy of a novel TB vaccine candidate
- (2009) Susan L. Baldwin et al. VACCINE
- Influence of Multidrug Resistance on Tuberculosis Treatment Outcomes with Standardized Regimens
- (2008) Anton Mak et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis
- (2008) Christopher Dye NATURE REVIEWS MICROBIOLOGY
- TBscore: Signs and symptoms from tuberculosis patients in a low-resource setting have predictive value and may be used to assess clinical course
- (2008) Christian Wejse et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now